A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients can discontinue their anti-VEGF therapy. Read more
George & Matilda encourages staff to support fire affected communities
George & Matilda has created a new initiative to support communities affected by the 2020 bushfires by incentivising staff to get out and visit impacted regions. Read more
Australian CL manufacturer pens long-term deal with Chinese medical firm
Australia’s Capricornia Contact Lens is set to take its specialty products to the lucrative Chinese market after signing a 10-year distribution deal with a major pharmaceutical and medical equipment distributer. Read more
Commission probes proposed EssilorLuxottica-GrandVision acquisition
EssilorLuxottica has reaffirmed its goal to complete the acquisition of optical retail giant GrandVision within the next 18 months following the announcement of a new investigation by the European competition watchdog. Read more
Chinese ophthalmologist and coronavirus whistle-blower dies
An ophthalmologist who Chinese authorities attempted to silence during the initial stages of the coronavirus outbreak has died after contracting the disease himself from a glaucoma patient. Read more
Questions over economic viability of MBS proposals
Proposed cuts to the rebate and fee for intravitreal injections will impact bulk billing services and access to treatment, Australia’s ophthalmic sector has warned. Read more
ADOA merger continues to progress
Recent changes to bylaws and constitutions are slowly bringing together Australia’s two dispensing organisations, following a 2019 commitment by the representative bodies to merge. Read more
QEI clinic unveils new cross-linking technology for corneal procedure
The Queensland Eye Institute (QEI) has become the first clinic in Australia to offer a new topography-guided corneal collagen cross-linking treatment to keratoconus patients. Read more
Warning to Australian eyecare professionals over coronavirus outbreak
Australian ophthalmologists have been warned that patients presenting with conjunctivitis could be infected with the deadly coronavirus, as the sector’s peak bodies urge eyecare professionals to be wary of people who have travelled from China. Read more
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the decision will lift treatment adherence rates across the country. Read more